Also, Bakar-Ateş et al. (2018) studied the effect of colchicine with concentrations of 0.1, 10, and 100 μg/ml in stopping the cell cycle and mRNA expression related to Matrix metalloproteinase-2 (MMP-2) on MCF-7 breast adenocarcinoma cells and found that colchicine at concentrations of 10 and 100 μg/ml significantly prevented cell viability. Here, MMP2 is linked to breast adenocarcinoma.